Evaluation of COVID-19 protease and HIV inhibitors interactions
Open Access
- 30 August 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 72 (1) , 1-8
Abstract
The epidemic of the novel coronavirus disease (COVID-19) that started in 2019 has evoked an urgent demand for finding new potential therapeutic agents. In this study, we performed a molecular docking of anti-HIV drugs to refine HIV protease inhibitors and nucleotide analogues to target COVID-19. The evaluation was based on docking scores calculated by AutoDock Vina and top binding poses were analyzed. Our results suggested that lopinavir, darunavir, atazanavir, remdesivir, and tipranavir have the best binding affinity for the 3-chymotrypsin-like protease of COVID-19. The comparison of the binding sites of three drugs, namely, darunavir, atazanavir and remdesivir, showed an overlap region of the protein pocket. Our study showed a strong affinity between lopinavir, darunavir, atazanavir, tipranavir and COVID-19 protease. However, their efficacy should be confirmed by in vitro studies since there are concerns related to interference with their active sites.Keywords
This publication has 23 references indexed in Scilit:
- Inhibition of SARS-CoV 3CL protease by flavonoidsJournal of Enzyme Inhibition and Medicinal Chemistry, 2019
- Design, Synthesis, and Pharmacokinetic Evaluation of Phosphate and Amino Acid Ester Prodrugs for Improving the Oral Bioavailability of the HIV-1 Protease Inhibitor AtazanavirJournal of Medicinal Chemistry, 2019
- HIV protease inhibitors: a review of molecular selectivity and toxicityHIV/AIDS - Research and Palliative Care, 2015
- Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell CultureAntimicrobial Agents and Chemotherapy, 2014
- PubChem's BioAssay DatabaseNucleic Acids Research, 2011
- Open Babel: An open chemical toolboxJournal of Cheminformatics, 2011
- LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug DiscoveryJournal of Chemical Information and Modeling, 2011
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Clinical Pharmacokinetics of DarunavirClinical Pharmacokinetics, 2007
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004